Charles River Laboratories Schedules Second-Quarter 2024 Earnings Release and Conference Call
Werte in diesem Artikel
Charles River Laboratories International, Inc. (NYSE: CRL) will release second-quarter 2024 financial results on Wednesday, August 7th, before the market opens. A conference call has been scheduled to discuss this information on Wednesday, August 7th, at 9:00 a.m. ET.
Investors will have the opportunity to listen to a live webcast of the conference call through the Investor Relations section of the Company's website at ir.criver.com. A replay will be accessible through the same website.
About Charles River
Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240716352337/en/
Ausgewählte Hebelprodukte auf Charles River Laboratories International
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Charles River Laboratories International
Der Hebel muss zwischen 2 und 20 liegen
Aktuelle Charles River Laboratories International Aktie News
Charles River Laboratories International Analysen
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Charles River Laboratories International nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen
| Datum | Rating | Analyst | |
|---|---|---|---|
| 14.12.18 | Charles River Laboratories International Buy | Deutsche Bank AG | |
| 19.09.17 | Charles River Laboratories International Sector Perform | RBC Capital Markets | |
| 30.11.16 | Charles River Laboratories International Equal Weight | Barclays Capital | |
| 06.09.16 | Charles River Laboratories International Sell | UBS AG | |
| 20.05.16 | Charles River Laboratories International Underweight | Barclays Capital |